Folgen
AR Moschen
AR Moschen
Professor of Medicine, Medical University Innsbruck
Bestätigte E-Mail-Adresse bei i-med.ac.at
Titel
Zitiert von
Zitiert von
Jahr
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
H Tilg, AR Moschen
Nature reviews immunology 6 (10), 772-783, 2006
39792006
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis
H Tilg, AR Moschen
Hepatology 52 (5), 1836-1846, 2010
26512010
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
AR Moschen, A Kaser, B Enrich, B Mosheimer, M Theurl, H Niederegger, ...
The Journal of Immunology 178 (3), 1748-1758, 2007
13532007
Inflammatory mechanisms in the regulation of insulin resistance
H Tilg, AR Moschen
Molecular medicine 14, 222-231, 2008
11552008
NAFLD and diabetes mellitus
H Tilg, AR Moschen, M Roden
Nature reviews Gastroenterology & hepatology 14 (1), 32-42, 2017
9042017
Microbiota and diabetes: an evolving relationship
H Tilg, AR Moschen
Gut 63 (9), 1513-1521, 2014
8462014
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ...
Journal of Crohn's and Colitis 3 (2), 47-91, 2009
6882009
The intestinal microbiota in colorectal cancer
H Tilg, TE Adolph, RR Gerner, AR Moschen
Cancer cell 33 (6), 954-964, 2018
6482018
Adiponectin and its receptors in non-alcoholic steatohepatitis
S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ...
Gut 54 (1), 117-121, 2005
5972005
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
H Tilg, AR Moschen
Trends in Endocrinology & Metabolism 19 (10), 371-379, 2008
5902008
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
C Grander, TE Adolph, V Wieser, P Lowe, L Wrzosek, B Gyongyosi, ...
Gut 67 (5), 891-901, 2018
5052018
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction
MM Richardson, JR Jonsson, EE Powell, EM Brunt, ...
Gastroenterology 133 (1), 80-90, 2007
5052007
Gut microbiome and liver diseases
H Tilg, PD Cani, EA Mayer
Gut 65 (12), 2035-2044, 2016
4902016
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
AR Moschen, H Tilg, T Raine
Nature Reviews Gastroenterology & Hepatology 16 (3), 185-196, 2019
3652019
Gut, inflammation and osteoporosis: basic and clinical concepts
H Tilg, AR Moschen, A Kaser, A Pines, I Dotan
Gut 57 (5), 684-694, 2008
3592008
Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases
H Tilg, AR Moschen
Clinical science 114 (4), 275-288, 2008
3552008
Food, immunity, and the microbiome
H Tilg, AR Moschen
Gastroenterology 148 (6), 1107-1119, 2015
3062015
Lipocalin-2: a master mediator of intestinal and metabolic inflammation
AR Moschen, TE Adolph, RR Gerner, V Wieser, H Tilg
Trends in Endocrinology & Metabolism 28 (5), 388-397, 2017
3022017
Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
H Tilg, AR Moschen, G Szabo
Hepatology 64 (3), 955-965, 2016
3012016
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression
AR Moschen, C Molnar, S Geiger, I Graziadei, CF Ebenbichler, H Weiss, ...
Gut 59 (9), 1259-1264, 2010
2952010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20